Cargando…
Influence of Alcohol on Phosphodiesterase 5 inhibitors Use in Middle- to Old-Aged Men: A Comparative Study of Adverse Events
INTRODUCTION: Some previous studies reported recreational use of phosphodiesterase type 5 (PDE-5) inhibitors by ingesting the medicine with alcohol in patients with erectile dysfunction, but the rate of misuse in general population has never been researched. AIM: To investigate the frequency of conc...
Autores principales: | Kim, Jong Nyeong, Oh, Jong Jin, Park, Dong Soo, Hong, Young Kwon, Yu, Young Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963111/ https://www.ncbi.nlm.nih.gov/pubmed/31444051 http://dx.doi.org/10.1016/j.esxm.2019.07.004 |
Ejemplares similares
-
Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study
por: Shirai, Masato, et al.
Publicado: (2018) -
Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
por: Sadovsky, R, et al.
Publicado: (2009) -
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil
por: Corona, Giovanni, et al.
Publicado: (2017) -
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study
por: Hallanzy, Jacqueline, et al.
Publicado: (2019) -
Erectile Dysfunction is Predictive Symptom for Poor Semen in Newlywed Men in Japan
por: Tsujimura, Akira, et al.
Publicado: (2019)